Company updateBusinessLine
Cipla US facility gets FDA No Action Indicated status
Positive+202 sources
GreyOak summary
Cipla Ltd's subsidiary, InvaGen Pharmaceuticals Inc, received a 'No Action Indicated' classification from the US FDA. This status follows an inspection of the New York manufacturing facility conducted between October 19 and October 22, 2026. The regulator found no objectionable conditions or regulatory violations during the visit.
What it affects
- CiplaCIPLAPositive +20
FDA inspection found no violations.Rolling sentiment Neutral -8
Source
Read the original at BusinessLineMore Cipla news
- DRI searches Cipla Mumbai office and depotEconomic Times · Regulatory ·
- Senco Gold, Adani, BSE, Cipla shares in focusMint · Market wrap ·
- GIFT Nifty down 5 pts; BSE, Bajaj Finance, AEL, HDFC Life, Senco Gold, Cipla focusBusiness Today · Market wrap ·
- Stocks to Watch: Urban Company, Senco Gold, ARSS Infra, Capri Global, SML Mahindra, Lemon,Moneycontrol · Company update ·
- Deven Choksey prefers Sun Pharma, Cipla for fresh buying; sees upside in Indian ITCNBC-TV18 · Stock view ·